Disturbing Picture Of Lilly, Zyprexa Promotion May Cost Them Over $1 Billion In Fines

Eli Lilly and federal prosecutors are discussing a possible settlement of both civil and criminal investigations that will amount to more than $1 billion in payments to federal and state governments. Lilly has been accused of breaking federal laws by “off-label marketing” its psychotherapeutic drug, Zyprexa, for uses not approved by the Food and Drug Admistration.